PubRank

Impact of Exercise on Prognostic Biomarkers Related to Prostate Cancer

Clinical Trial ID NCT03397030

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT03397030

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Health behaviors of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol 2005 4.10
2 Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003 3.07
3 A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. Prev Med 2005 2.85
4 Role of diet in prostate cancer development and progression. J Clin Oncol 2005 2.29
5 Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients. Eur Urol 2008 2.20
6 Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis. J Clin Oncol 2007 2.06
7 Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2009 1.90
8 Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol 2010 1.87
9 A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2013 1.83
10 Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 2007 1.31
11 Tumor markers in prostate cancer I: blood-based markers. Acta Oncol 2011 1.28
12 Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 2012 1.28
13 Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 2006 1.25
14 Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome. Invest Ophthalmol Vis Sci 2001 1.22
15 The relationship between cancer-related fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage 2007 1.16
16 Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE. Urology 1999 1.14
17 Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil 2007 1.13
18 Impact of diet on prostate cancer: a review. Prostate Cancer Prostatic Dis 2005 1.12
19 Cancer-related fatigue: a practical review. Ann Oncol 2011 1.11
20 Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symptom Manage 2011 1.04
21 Measurement of serum prostate-specific membrane antigen, a new prognostic marker for prostate cancer. Urology 1998 0.96
22 Prostate-specific antigen: any successor in sight? Rev Urol 2013 0.95
23 Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study. PM R 2009 0.88
24 A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial. BMC Cancer 2009 0.82
25 Predicting success in the tactical air combat party training pipeline. Mil Med 2011 0.78
26 Predictors of physical activity and quality of life in New Zealand prostate cancer survivors undergoing androgen-deprivation therapy. N Z Med J 2010 0.78
27 Fatigue biomarker index: an objective salivary measure of fatigue level. Accid Anal Prev 2011 0.77
28 Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progression in patients undergoing radical prostatectomy. Prostate 2011 0.77
Next 100